Clinical Trial Update: Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of tolvaptan for cardiac-induced edema in patients with heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Samsca (tolvaptan)

Snippet

Sponsor: Taiwan Otsuka Pharm. Co., Ltd | Conditions: Cardiac-induced Edema | Phase 3 | Status: COMPLETED